DrugDashboards

Dexmethylphenidate Hydrochloride

Dexmethylphenidate Hydrochloride · DEXMETHYLPHENIDATE HYDROCHLORIDE 5 mg/1 · Tablet · Oral · Lupin Pharmaceuticals,Inc.

NDC 43386-0860-01 · 100 TABLET in 1 BOTTLE · ANDA · View full market →

The short version

8 companies supply this market — a reasonable cushion if one runs into trouble. The price has jumped 30% in a year, to $0.1883 per unit — sharp rises like this often mean supply is already tightening.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 10702-0107-01) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of sale
$0.4016per unit
middle half $0.3546$0.4438 · 4,943 plans · Apr 1, 2026
Est. net of rebates
≈ $0.4016
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
90%of plans cover it
tier 3 · prior auth 19% · step therapy 0% · qty limit 87%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.

NADAC price per unit

$0$0.5$1.00Feb 2016Jun 2022$0.1883
77 price points · per · last surveyed Invalid Date · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Medicaid spend (2022)

$718
42 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for dexmethylphenidate hydrochloride (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA204534
TE code
AB
Approval date
Dec 4, 2015
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Dexmethylphenidate Hydrochloride (Tablet)

LabelerStrengthFirst seenLast seen
Bryant Ranch PrepackDEXMETHYLPHENIDATE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackDEXMETHYLPHENIDATE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 3, 2026
Ascend Laboratories, LLCDEXMETHYLPHENIDATE HYDROCHLORIDE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCDEXMETHYLPHENIDATE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCDEXMETHYLPHENIDATE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Cranbury Pharmaceuticals, LLCDEXMETHYLPHENIDATE HYDROCHLORIDE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Cranbury Pharmaceuticals, LLCDEXMETHYLPHENIDATE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Cranbury Pharmaceuticals, LLCDEXMETHYLPHENIDATE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Kvk-Tech, IncDEXMETHYLPHENIDATE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Kvk-Tech, IncDEXMETHYLPHENIDATE HYDROCHLORIDE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Kvk-Tech, IncDEXMETHYLPHENIDATE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals,Inc.DEXMETHYLPHENIDATE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals,Inc.DEXMETHYLPHENIDATE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals,Inc.DEXMETHYLPHENIDATE HYDROCHLORIDE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Nivagen Pharmaceuticals, Inc.DEXMETHYLPHENIDATE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Nivagen Pharmaceuticals, Inc.DEXMETHYLPHENIDATE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Sandoz IncDEXMETHYLPHENIDATE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Sandoz IncDEXMETHYLPHENIDATE HYDROCHLORIDE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Sandoz IncDEXMETHYLPHENIDATE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.DEXMETHYLPHENIDATE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.DEXMETHYLPHENIDATE HYDROCHLORIDE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.DEXMETHYLPHENIDATE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackDEXMETHYLPHENIDATE HYDROCHLORIDE 2.5 mg/1Jul 15, 2026Aug 31, 2026
Novartis Pharmaceuticals CorporationDEXMETHYLPHENIDATE HYDROCHLORIDE 5 mg/1Jul 15, 2026Jul 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Dexmethylphenidate Hydrochloride — NDC 43386-0860-01," retrieved September 3, 2026, https://drugdashboards.com/drug/43386086001.

Free to cite with attribution — see how the data is put together.